NCT00025922View on ClinicalTrials.gov

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

October 31, 2003

Conditions
HIV Infection
Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00025922 - Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load | Biotech Hunter | Biotech Hunter